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E-mail address: tsuzuki@pharm.hokudai.ac.jp (T. SThe neural adaptor protein FE65 interacts with the amyloid b-protein precursor (APP). In osmoti-
cally stressed cells, the membrane APP-tethered FE65 is released into the cytoplasm and translo-
cates to the nuclear matrix, where it stabilizes p53 via a non-canonical pathway. In this study, we
found that the second phosphotyrosine interaction domain (PI2) of FE65 mediated its trans-accu-
mulation in the nuclear matrix of osmotically stressed cells. The carboxyl-terminal half of FE65,
which contains the PI2 domain, failed to stabilize p53, suggesting that the amino-terminal half of
the protein plays an important role in the stabilization of p53 in osmotically stressed cells.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
FE65 is a cytoplasmic adaptor protein that interacts with vari-
ous proteins [1], including the amyloid b-protein precursor (APP),
which is a causative factor of Alzheimer’s disease. FE65 is thought
to function in the regulation of various cellular events by interact-
ing with these proteins. Although FE65 knockout mice exhibit
impairment of learning and memory abilities [2] and an abnormal-
ity in brain structure [3], the precise physiological function of FE65
remains unclear.
A recent biochemical analysis of FE65 suggests that this protein
is involved in cell stress and/or DNA damage [4]. A ﬁxed population
of cytoplasmic FE65 is tethered to the membrane by binding to
APP. In turn, the tethered FE65 is released into the cytosol via
the phosphorylation of APP in hyperosmotically stressed cells
[5–7]. The released FE65 then trans-accumulates in the nuclear
matrix and participates in DNA damage response by inducing
cH2AX and by stabilizing p53 [7,8]. FE65 comprises one WW
domain, which is composed of two conserved tryptophan (W) res-
idues spaced 20–22 residues apart within the consensus-sequence-
containing domain [9], and binds to a proline-rich sequence andchemical Societies. Published by E
PI, phosphotyrosine interac-
nuclear matrix
uzuki).two phosphotyrosine interacting domains (PI1 and PI2); however,
the roles of these domains in the nuclear-matrix accumulation of
FE65 and in the stabilization of p53 in osmotically stressed cells re-
mains unknown. In this study, we identiﬁed the intramolecular re-
gions of FE65 required for the nuclear-matrix trans-accumulation
of FE65 and for the stabilization of p53 therein in hyperosmotically
stressed cells.
2. Materials and methods
2.1. Antibodies and plasmids
The rabbit polyclonal anti-enhanced green ﬂuorescent protein
(EGFP) (598B, MBL, Japan), mouse monoclonal anti-actin (C4,
Chemicon/Millipore, USA), and anti-FLAG (M2, Sigma/Aldrich,
USA) antibodies were purchased. To prepare FE65-deletion mu-
tants fused to EGFP, the cDNA of FE65 [7] was ampliﬁed by PCR
using speciﬁc primers. The PCR products were digested with
KpnI/BamHI and cloned into the pEGFP-N3 vector (Clontech/Life
Technologies, USA) to generate pEGFP-N, pEGFP-C, pEGFP-DPI1,
pEGFP-DPI2, pEGFP-DPI1DPI2, and pEGFP-PI2. For FLAG-tagged
constructs, the PCR products were digested with NheI/NotI and
cloned into the pcDNA3.1NFLAG vector [6] to generate
pcDNA3.1NFLAG-FE65N and pcDNA3.1NFLAG-FE65C. pcDNA3.1N-
FLAG-FE65full and pcDNA3.1NFLAG-p53 were as described previ-
ously [6,8].lsevier B.V. All rights reserved.
766 T. Kawai et al. / FEBS Letters 584 (2010) 765–7692.2. Cell culture, plasmid transfection, sorbitol treatment, subnuclear
fractionation, and immunoblotting of proteins
Amouse Neuro2a cell line was used throughout this study. Plas-
mid transfection was performed using Lipofectamine 2000 (Invit-
rogen/Life Technologies, USA). For sorbitol treatment, cells were
treated with 0.5 M sorbitol for 45 min. For subnuclear fraction-
ation, proteins were extracted consecutively using buffers that
were adequate to obtain membrane/cytosol (MC), nucleoplasm
(NP), DNA-binding proteins (DNA-bp), RNA-binding proteins
(RNA-bp), and nuclear-matrix (NM) fractions [7]. For immunoblot-
ting of proteins, proteins were separated by SDS–PAGE, transferred
onto a nitrocellulose membrane, and were then incubated with the
primary antibody. After incubation with the secondary antibody,
i.e., anti-rabbit or anti-mouse IgG conjugated to horseradish perox-
idase (GE Healthcare Lifescience, USA), immunoreactive proteins
were detected by ECL (GE Healthcare) and were quantiﬁed using
the luminescent image analyzer LAS-4000mini (Fujiﬁlm, Japan).
The proteins detected using the anti-EGFP antibody were standard-
ized to actin levels, which were assessed using an anti-actin
antibody.
2.3. Methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay
MTT (10 lL of a 5 mg/mL solution; Sigma/Aldrich) was added to
the cells for a period of 6 h. The reaction was halted by the addition
of 100 lL of 0.04 N HCl in isopropanol and optical density at
570 nm (with a reference at 630 nm) was measured using a micro-
plate reader.3. Results
3.1. Role of the N- and C-terminal regions of FE65 in its nuclear-matrix
trans-accumulation and in the suppression of the reduction of cell
viability in osmotically stressed cells
To identify the domains of FE65 required for its nuclear-matrix
trans-accumulation in osmotically stressed cells, we ﬁrst examined
the N-terminal (FE651–368) and C-terminal (FE65369–710) regions of
FE65 tagged with EGFP at their C termini (Fig. 1A). Cells expressing
FE65 were treated with (+) or without () sorbitol for 45 min and
the cell lysates were fractionated into crude lysate (CL), MC, NP,
DNA-bp, RNA-bp, and NM, as described previously [7]. The distri-
bution of the proteins was analyzed using immunoblotting
(Fig. 1B), which revealed recovery of FE65 proteins in the NM frac-
tion (Fig. 1C). EGFP-full was largely recovered in the MC fraction,
regardless of sorbitol treatment, and approximately 20% of EGFP-
full was recovered in the NM fraction after sorbitol treatment
(Fig. 1B and panel a of Fig. 1C), as was observed for endogenous
FE65 [7]. This result suggests that EGFP tagging had no effect on
the localization of the protein. EGFP-N was largely recovered in
the MC fraction, as was EGFP-full; however, almost no protein
was recovered in the NM fraction (Fig. 1B and panel b in Fig. 1C).
In sorbitol-treated cells, the recovery of EGFP-N in the NM fraction
was much lower than that observed for EGFP-full.
In contrast to EGFP-N, EGFP-C showed a distribution that was
similar to that of EGFP-full (Fig. 1B and panel c of Fig. 1C). We as-
sessed the exact net recovery of FE65 in NM fractions of cells after
sorbitol treatment by subtracting the amount of FE65 detected in
the NM fraction of cells prior to the treatment (panel d of
Fig. 1C). The net trans-accumulation of EGFP-C was slightly in-
creased in the NM fraction after sorbitol treatment (recovery,
23.4 ± 2.6%), while that of EGFP-N was markedly decreased (recov-
ery, 1.5 ± 1.1%), when compared with EGFP-full (recovery,
16.2 ± 2%). These results indicate clearly that the nuclear matrixtrans-accumulation of FE65 in osmotically stressed cells was
dependent on its C-terminal domain.
Knockdown of FE65 increases apoptosis in cells treated with
sorbitol over a long period [7], which suggests that FE65 plays a
role in cell viability. Therefore, we assayed the viability of cells
expressing FE65 after long-term sorbitol treatment (Fig. 1D). Cells
with or without () expression of EGFP-full, EGFP-N, or EGFP-C
were treated with sorbitol for 24 h and cell viability was quantiﬁed
using an MTT assay. Cells expressing either EGFP-full or EGFP-N
retained their viability at levels that were similar to those of the
control (). In addition, approximately 70% of treated cells were
viable compared with non-treated cells (100%), while cells express-
ing EGFP-C had a signiﬁcantly reduced viability, similarly to what
was observed in FE65 knockdown cells [7]. These results suggest
that the C-terminal domain of FE65 was essential for the trans-
accumulation of FE65 in the nuclear matrix and that its N-terminal
domain prevented the reduction in the viability of cells after
hyperosmotic stress. EGFP-C may behave as a dominant-negative
molecule to endogenous FE65 and suppress the function of endog-
enous FE65 during the promotion of cell survival.
3.2. Role of the N-terminal region of FE65 in the stabilization of p53
FE65 stabilizes p53 in the nuclear matrix of osmotically stressed
cells [8]. To identify the intramolecular region of FE65 that is
responsible for this function, we examined p53 stability in cells
expressing N-terminally FLAG-tagged full-length FE65 (NFLAG-
FE65full), the N-terminal half of FE65 (NFLAG-FE65N), or the C-ter-
minal half of FE65 (NFLAG-FE65C) (Fig. 2). Cells expressing the
NFLAG-p53 and NFLAG-FE65 proteins were treated with (Fig. 2A,
lanes 9–16) or without (lanes 1–8) sorbitol, and cell lysates were
subjected to immunoblotting using anti-FLAG (upper panel) or
anti-actin (lower panel) antibodies. The levels of expression of
NFLAG-p53 were almost identical in the absence of sorbitol treat-
ment, regardless of the nature of the NFLAG-FE65 proteins that
were co-expressed (lanes 1–8). Treatment of these cells with sorbi-
tol (lanes 9–16) led to the stabilization of NFLAG-p53 in cells that
co-expressed NFLAG-FE65full, which was enhanced by the increase
in the expression of NFLAG-FE65full (Fig. 2A, lanes 10–12, and
Fig. 2B). In contrast, NFLAG-FE65N and NFLAG-FE65C failed to sta-
bilize NFLAG-p53 in sorbitol-treated cells (Fig. 2A, lanes 13–16,
and Fig. 2B). As observed in Fig. 1, NFLAG-FE65N failed to trans-
accumulate in the nuclear matrix, while NFLAG-FE65C and
NFLAG-FE65full accumulated in the nuclear matrix in sorbitol-
treated cells (data not shown). These observations indicate that
the N-terminal half of FE65 plays an important role in the stabiliza-
tion of p53 in the nuclear matrix of osmotically stressed cells,
although we cannot rule out the possibility that NFLAG-FE65C
may require the N-terminal half of the protein to retain a structure
that is suitable for its role in the stabilization of p53.
3.3. The PI2 domain was required for the nuclear-matrix trans-
accumulation of FE65
The PI1 and PI2 domains located in the C-terminal region of
FE65 are candidate domains for the mediation of the trans-accu-
mulation of FE65 in the nuclear matrix. To determine which do-
main plays this role, we generated the following deletion
mutants of FE65: EGFP-DPI1DPI2, EGFP-DPI1, and EGFP-DPI2
(Fig. 3A). Cells expressing these mutant FE65 proteins were treated
with sorbitol, and the trans-accumulation of the proteins in the nu-
clear matrix was examined (Fig. 3B and C). Interestingly, EGFP-
DPI2 and EGFP-DPI1DPI2 lost the ability to trans-accumulate in
the nuclear matrix in cells treated with sorbitol, while EGFP-DPI1
trans-accumulated successively in the nuclear matrix. The recov-
ery of EGFP-DPI1 in the nuclear matrix was approximately 30%
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Fig. 1. Role of the C-terminal domain of FE65 in its trans-accumulation in the nuclear matrix of hyperosmotically stressed cells. (A) Schematic structure of the FE65 proteins
used in this study. The human FE65 (FE65) and EGFP-full, EGFP-N, and EGFP-C, which were tagged C-terminally with EGFP, are indicated, as are the WW (255–283), PI1 (369–
509), and PI2 (529–661) domains. The numbers indicate amino-acid positions. (B) Subnuclear distribution of the FE65 proteins. Cells expressing the various FE65 proteins
were treated with (+) or without () sorbitol and subjected to subnuclear fractionation. Proteins were detected by immunoblotting using anti-EGFP or anti-actin antibodies.
CL, crude lysate; MC, membrane and cytosol; NP, nucleoplasm; DNA-bp, DNA-binding proteins; RNA-bp, RNA-binding proteins; NM, nuclear matrix. (C) Recovery of FE65
proteins in the nuclear matrix. The proteins (a, EGFP-full; b, EGFP-N; c, EGFP-C) in the CL and NM fractions of panel b were quantiﬁed and standardized to actin and their
recovery (%) in the NM fraction vs. total amount (100% in CL) is shown. Cells treated with (+) and without () sorbitol were compared. The net recovery (panel d) was
calculated by subtracting the amount detected in the NM of cells treated without sorbitol from that of cells treated with sorbitol. Data represent the mean ± standard
deviation (S.D.) (n = 3). *P < 0.05; ***P < 0.005, as assessed using a Student’s t-test against EGFP-full in panel d. (D) Cell viability after long-term sorbitol treatment. Cells
expressing the indicated proteins (EGFP-full, EGFP-N, and EGFP-C) or control cells () were treated with sorbitol for 24 h and cell viability was measured using an MTT assay.
Cell viability was compared with that of untreated cells (100%). Data represent the mean ± S.D. (n = 3). n.s., not signiﬁcant; *P < 0.05, as assessed using a Student’s t-test
against the control ().
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Fig. 2. Role of the N-terminal region of FE65 in the stabilization of p53. (A) Effects of the FE65 mutants in the stabilization of p53 in osmotically stressed cells. Cells expressing
NFLAG-p53 and NFLAG-FE65full (full), NFLAG-FE65N (N), or NFLAG-FE65C (C) were treated with (lanes 9–16) or without (lanes 1–8) sorbitol. (+) Cells transfected with the
indicated plasmid; () cells transfected with vector alone. Numbers represent the amount (ng) of plasmids transfected. The cells were lysed and the cell lysates were
subjected to immunoblotting using anti-FLAG (top) and anti-actin (bottom) antibodies. (B) Quantiﬁcation of the levels of NFLAG-p53 in the nuclear matrix of the sorbitol-
treated cells shown in panel a. The protein band intensities of NFLAG-p53 in sorbitol-treated cells (A, lanes 10, 12, 14, and 16) were quantiﬁed and normalized to the value
observed without co-expression of the NFLAG-FE65 proteins (, expression of NFLAG-p53 alone; lane 10 in panel a). The results represent the average of three experiments.
Error bar indicates the standard error. *P < 0.05, as assessed using a Student’s t-test.
T. Kawai et al. / FEBS Letters 584 (2010) 765–769 767(panel b of Fig. 3C), which was in agreement with the results ob-
served for EGFP-C (Fig. 1C), while the recovery of EGFP-DPI1DPI2
(2.7 ± 1.4%) and EGFP-DPI2 (1.9 ± 1.1%) was extremely low (panels
a and c of Fig. 3C). We conﬁrmed this observation using EGFP-PI2
(Fig. 3A), which was detected in the NM fraction of cells treated
with sorbitol with a recovery of 12.3 ± 3.4% (Fig. 3B and C).
Although the trans-accumulation efﬁciency of EGFP-PI2 was lower
than that of EGFP-DPI1, this result conﬁrmed that PI2 is the mini-
mum region required for the trans-accumulation of FE65. We also
assessed the exact net recovery of FE65 in NM fractions (panel e of
Fig. 3C). The trans-accumulation of EGFP-DPI1DPI2 and EGFP-DPI2was signiﬁcantly decreased in the NM fraction of cells treated with
sorbitol. EGFP-DPI1 and EGFP-PI2 did not exhibit a signiﬁcant dif-
ference when compared with the recovery of EGFP-full (for EGFP-
full, see Fig. 1C). These results clearly indicate that the PI2 domain
mediated the nuclear-matrix trans-accumulation of FE65.
4. Discussion
In this report, we described two functional regions of FE65 that
play an important role in the trans-accumulation of FE65 and sta-
bilization of p53 therein in osmotically stressed cells.
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Fig. 3. The PI2 domain was required for the nuclear matrix trans-accumulation of FE65. (A) Schematic structure of the FE65 proteins. EGFP-DPI1DPI2, EGFP-DPI1, EGFP-DPI2,
and EGFP-PI2, which were tagged C-terminally with EGFP, are shown. The three protein-interaction domains and the numbers were described in Fig. 1. (B) Subnuclear
distribution of the FE65 proteins. Cells expressing the various proteins were treated with (+) or without () sorbitol, subjected to subnuclear fractionation, and analyzed as
described in Fig. 1B. (C) Recovery of FE65 proteins in the nuclear matrix. Proteins a, EGFP-DPI1DPI2; b, EGFP-DPI1; c, EGFP-DPI2; and d, EGFP-PI2) in the CL and NM fractions
of panel b were quantiﬁed and their net recoveries (panel e) were calculated as described in Fig. 1. Data represent the mean ± S.D. (n = 3). ***P < 0.005, as assessed using a
Student’s t-test against EGFP-full (in Fig. 1C, panel d).
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required for the nuclear-matrix trans-accumulation of FE65 in
osmotically stressed cells. Previous observations showed that (1)
the PI2 domain interacts with the cytoplasmic NPXY (Asn-Pro-
X-Tyr) motif of APP in a tyrosine phosphorylation-independent
manner [10], (2) phosphorylation of Thr668 of the APP695 isoform
induces a conformational change in the cytoplasmic region of APP,
which includes the NPTY (Asn-Pro-Thr-Tyr) motif (this motif
interacts with FE65 [5,11,12]), (3) this phosphorylation lowers
the binding afﬁnity of PI2 to the APP cytoplasmic peptide [13],
and (4) nuclear trans-location of FE65 is dependent on APP and
on its phosphorylation [6,7]. Taking these previous observations
and the results presented here together, the PI2 domain of FE65
and APP phosphorylation play a central role in cellular responses
to hyperosmotic stress.
Previously, we showed that the APP intracellular domain (AICD)
fragment, which is generated by the serial cleavage of APP by a-b-
secretase and c-secretase, inhibits the nuclear-matrix accumula-
tion of FE65 in osmotically stressed cells [7]. This observation
seems to be in agreement with the present ﬁndings, as the PI2 do-
main of FE65 can be masked by binding to AICD.
Second, the N-terminal region of FE65, which includes the WW
domain, plays an important role in the stabilization of p53 in
osmotically stressed cells. Previously, we showed that the pro-
line-rich region of p53 is required for the nuclear-matrix accumu-
lation of this protein in osmotically stressed cells [8]. In general,
the WW domain recognizes the proline-rich sequence [14]. How-
ever, p53 does not interact directly with FE65 [8] and the N-termi-
nal region of FE65 was required for the prevention of the reduction
in the viability of cells after long-term sorbitol treatment. Our pre-
vious and current results suggest that the N-terminal region of
FE65 may function to prevent p53 degradation during osmotic
stress by suppressing the proteasome degradation system [8].
Because the metabolic stabilization of p53 via this non-canoni-
cal pathway may be important for cellular stress responses [8],
understanding the mechanisms that underlie FE65 trans-accumu-lation in the nuclear matrix may provide novel insights into how
cells respond and survive to cellular stresses, which in turn will
promote the understanding of the pathobiology of neurodegenera-
tive diseases, including Alzheimer’s disease.
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